Skip to main content
. 2022 Apr 18;17(4):e0266781. doi: 10.1371/journal.pone.0266781

Fig 1. Temporal IgM response to SARS-CoV-2 epitopes.

Fig 1

IgM antibody response to respective SARS-CoV-2 epitopes at baseline, week 2, week 4, month 3 and month 6 in subjects administered Pfizer-BioNTech COVID-19 vaccine at week 0 and week 3. Antibody response is reported in Genalyte response units (GRU). NS represents a p-value >0.05, * represents a p-value ≤ 0.05, ** represents a p-value ≤ 0.01, *** represents a p-value ≤ 0.001, **** represents a p-value ≤ 0.0001.